Comparison Between Oral Melatonin and Hydroxyzine in Pediatric Patients Undergoing Adenotonsillectomy
NCT ID: NCT05680584
Last Updated: 2023-12-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE1
78 participants
INTERVENTIONAL
2023-02-01
2024-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary outcomes:
1. Ease of parenteral separation.
2. The compliance to anesthesia induction in pediatric patients.
The secondary outcomes:
1. Assessment of postoperative pain.
2. Time to first analgesic request.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Melatonin
Preoperative oral melatonin 0.1mg/ kg in 10ml apple juice one hour before induction of anesthesia
Melatonin 3 MG
0.1 mg/ kg melatonin in 10 ml apple juice 1 hour before induction of anesthesia
Hydroxyzine
Preoperative oral hydroxyzine 1mg/ kg in 10ml apple juice one hour before induction of anesthesia
Hydroxyzine Pill
1 mg/ kg hydroxyzine in 10 ml apple juice 1 hour before induction of anesthesia
placebo
10ml apple juice one hour before induction of anesthesia
Placebo
10 ml apple juice 1 hour before induction of anesthesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Melatonin 3 MG
0.1 mg/ kg melatonin in 10 ml apple juice 1 hour before induction of anesthesia
Hydroxyzine Pill
1 mg/ kg hydroxyzine in 10 ml apple juice 1 hour before induction of anesthesia
Placebo
10 ml apple juice 1 hour before induction of anesthesia
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Sex: male and female
3. Age: from 3 to 10 years old
4. Children scheduled for adenotonsillectomy
Exclusion Criteria
2. History of an autoimmune disease
3. Concurrent use of immunosuppressive treatment
4. Sleep disturbances, speech or communication problems
5. allergic to hydroxyzine, cetirizine, or other derivatives of piperazine, aminophylline, and ethylenediamine.
6. hydroxyzine is contraindicated in patients with acute porphyria
\-
3 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sarah Mohamed Aly Omar Mousa
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Omar
Role: STUDY_DIRECTOR
Minia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sarah Omar
Al Minyā, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Hanafy
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sarah Omar
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
505/2022
Identifier Type: -
Identifier Source: org_study_id